Sun exposure, sunbeds and sunscreens and melanoma. what are the controversies?

Current Oncology Reports

Volumn 15, Issue 6, 2013, Pages 526-532

  Bataille, Veronique ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

DNA repair; Melanoma; Sun exposure; Sunbeds

Indexed keywords

PSORALEN; SUNSCREEN; VITAMIN D; VITAMIN D RECEPTOR;

CANCER RISK; DEVICES; EXCISION REPAIR; GENETIC POLYMORPHISM; HUMAN; MELANOMA; RADIATION INJURY; REVIEW; RISK ASSESSMENT; SKIN CARCINOMA; SUN EXPOSURE; SUNBED; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

BEAUTY CULTURE; HUMANS; MELANOMA; NEOPLASMS, RADIATION-INDUCED; RISK FACTORS; SKIN NEOPLASMS; SUNBATHING; SUNSCREENING AGENTS; ULTRAVIOLET RAYS; VITAMIN D DEFICIENCY;

EID: 84890060947     PISSN: 15233790     EISSN: 15346269     Source Type: Journal    
DOI: 10.1007/s11912-013-0342-4     Document Type: Review

References (72)

1. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 2005;41:45-60.
2. Bataille V, Winnett A, Sasieni P, et al. Exposure to the sun and sunbeds and the risk of cutaneous melanoma in the UK. A case control study. Eur J Cancer. 2004;40:429-35.
3. Bataille V, Boniol M, De Vries E, et al. A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur J Cancer. 2005;41:2141-9.
4. • Olsen CM, Green AC, Zens MS, et al. Anthropometric factors and risk of melanoma in women: a pooled analysis. Int J Cancer. 2008;122:1100-8. This is a very interesting study showing the association between melanoma and height and weight.
5. Sergentianes TN, Antoniadis AG, Gogas H, et al. Obesity and risk of malignant melanoma: a meta-analysis of cohort and case-control studies. Eur J Cancer. 2013;49:642-57.
6. Iles MM, Law MH, Stacey SN, et al. A variant in FTO shows an association with melanoma risk not due to BMI. Nat Genet. 2013;45:428-32.
7. Speliotes E, Willer C, Berndt S, et al. Association analyses of 249,796 individuals reveal eighteen new loci associated with body mass index. Nat Genet. 2010;42:937-48.
8. Bohm M, Schiller M, Luger TA. Non-pigmentary actions of alpha-melanocyte-stimulating hormone-lessons from the cutaneous melanocortin system. Cell Mol Biol. 2006;30:61-8.
9. Mountjoy K. Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes. Biochem J. 2010;428:305-24.
10. Levine H, Afek A, Shamiss A, et al. Country of origin, age at migration and risk of cutaneous melanoma: a migrant cohort study of 1,100,000 Israeli men. Int J Cancer. 2013;133:486-94.
11. Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma. A systematic review of epidemiological studies. Cancer Causes Control. 2001;12:69-82.
12. Bataille V, Snieder H, MacGregor AJ, et al. Genetics of risk factors for melanoma: an adult twin study of nevi and freckles. J Natl Cancer Inst. 2000;92:457-63.
13. Zhu G, Duffy DL, Eldridge A, et al. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am J Hum Genet. 1999;65:483-92.
14. Wachsmuth RC, Gaut RM, Barrett JH, et al. Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study. J Invest Dermatol. 2001;117:348-52.
15. Bataille V, Grulich A, Sasieni P, et al. The association between naevi and melanoma in populations with different sun exposure: a joint case-control study of melanoma in the UK and Australia. Br J Cancer. 1998;77:505-10.
16. MacLennand R, Kelly JW, Rivers JK, et al. The Eastern Australian Childhood Naevus Study: site differences in density and size of melanocytic nevi in relation to latitude and phenotype. J Am Acad Dermatol. 2003;48:367-75.
17. Fritschi L, McHenry P, Green A, et al. Naevi in childhood in Scotland and Australia. Br J Dermatol. 1994;130:590-603.
18. Chang YM, Newton-Bishop JA, Bishop DT, et al. A pooled analysis of melanocytic naevus phenotype and the risk of cutaneous melanoma. Int J Cancer. 2009;124:420-8.
19. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer. 2005;41:28-34.
20. Baade PD, Green AC, Smithers BM, et al. Trends in melanoma incidence among children: possible influence of sun protection programs. Expert Anticancer Ther. 2011;11:661-4.
21. Coory M, Baade P, Aitken J, et al. Trends in situ and invasive melanoma in Queensland, Australia 1982-2002. Cancer Causes Control. 2006;17:21-2.
22. De Vries E, Boniol M, Dore JF, et al. Lower incidence but thicker melanomas in eastern Europe before 1992: a comparison with western Europe. Eur J Cancer. 2004;40:1045-52.
23. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102:605-13.
24. http://seer.cancer.gov/faststats/selections.php?run&output= 2&data=1&statistic=2&year=200802&race=2&sex=1&age= 1&series=cancer&cancer=53.
25. Whiteman DC, Bray CA, Siskind V. A comparison of the anatomic distribution of cutaneous melanoma in two different populations with different levels of sunlight: the west of Scotland and Queensland Australia 1982-2001. Cancer Causes Control. 2007;18:485-91.
26. Bulliard JD, De Weck D, Fisch T, et al. Detailed distribution of melanoma and sunlight exposure: aetiological patterns from a Swiss series. Ann Oncol. 2007;18:789-94.
27. Larue L, de Vuyst F, Delmas V. Modeling melanoblast development. Cell Mol Life Sci. 2013;70:1067-79.
28. • Bonaventure J, Domingues MJ, Larue L. Cellular and molecular mechanisms controlling the migration of melanocytes and melanoma cells. Pigment Cell Melanoma Res. 2013;26:316-25. This study illustrates the differences in behaviour of melanocytes at different body sites.
29. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353:2135-47.
30. • Bataille V, Kato BS, Falchi M, et al. Nevus size and number are associated with telomere length and represent potential markers of a reduced senescence in vivo. Cancer Epidemiol Biomarkers Prev. 2007;16:1499-502. This was the first study linking telomere biology and melanoma link via a high number of naevi.
31. Han J, Qureshi AA, Prescott J, et al. A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol. 2009;129:415-21.
32. Gandini S, Sera F, Cattaruzza P, et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer. 2005;41:2040-59.
33. Bataille V, Sasieni P, Grulich A, et al. Solar keratoses: a risk factor for melanoma but negative association with melanocytic naevi. Int J Cancer. 1998;78:8-12.
34. Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Green AC. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst. 2003;95:806-12.
35. Berwick M, Armstron A, Ben-Porat L, et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst. 2005;97:195-9.
36. Wangari-Talbot J, Chen S. Genetics of melanoma. Front Genet. 2013;3:330.
37. Jiang Y, Rabbi M, Kim M, et al. UVA generates pyrimidine dimers in DNA directly. Biophys J. 2009;96:1151-8.
38. Larue L, Beerman F. Cutaneous melanoma in genetically modified animals. Pigment Cell Res. 2007;480:485-97.
39. Luo C, Sheng J, Hu MG, et al. Loss of ARF sensitises transgenic BRAF600E mice to UV induced melanoma via suppression of XPC. Cancer Res. 2013;73:4337-48.
40. Budden T, Bowden A. The role of altered nucleotide excision repair and UVB induced DNA damage in melanogenesis. Int J Mol Sci. 2013;14:1132-51.
41. Spatz A, Giglia-Mari G, Benhamou S, et al. Association between DNA repair deficiency and high levels of p53 mutations in melanoma of xeroderma pigmentosum. Cancer Res. 2001;61:2480-6.
42. McCullough LE, Santella RM, Cleveland RJ, et al. Polymorphisms in DNA repair genes, recreational physical activity and breast cancer risk. Int J Cancer. 2013. doi: 10.1002/ijc.28383.
43. Rapin I. Disorders of nucleotide excision repair. Handb Clin Neurol. 2013;113:1637-50.
44. Dutton-Regester K, Kakavand H, Aoude LG, et al. Melanomas of unknown primary have a mutation profile consistent with cutaneous sun exposed melanoma. Pigment Cell Melanoma Res. 2013. doi: 10.1111/pcmr.12153.
45. Yang D, Zhu Z, Wang, et al. Expression profiles analysis of pancreas cancer. 2013;17:311-7.
46. Turajlic S, Furney SJ, Lambros MB, et al. Whole genome sequencing of matched primary and metastatic acral melanomas. Genome Res. 2012;22:196-207.
47. Furney SJ, Turajlic S, Stamp G, et al. Genome sequencing of mucosal melanomas reveal that they are driven by distinct mechanisms from cutaneous melanoma. J Pathol. 2013;230:261-9.
48. Boniol M, Autier P, Boyle P, et al. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ. 2012;345:e4557.
49. Gamblicher T, Bader A, Vojvodic M, et al. Impact of UVA exposure on psychological parameters and circulating serotonin and melatonin. BMC Dermatol. 2002;2:6.
50. Stanganelli I, Gandini S, Magi S, et al. Sunbed use among subjects at risk of melanoma: an Italian survey of the ban. Br J Dermatol. 2013;169:351-7.
51. Watson M, Holamn PM, Fox KA, et al. Preventing skin cancer through reduction of indoor tanning. Current evidence. Am J Prev Med. 2013;44:682-9.
52. Wehner MR, Shive ML, Chren MM, et al. Indoor tanning and non melanoma skin cancer: systematic review and meta-analysis. BMJ. 2012;345:e5909.
53. Stern RS. PUVA Follow-Up Study. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy. J Am Acad Dermartol. 2002;66:553-62.
54. Antonio C, Kosmadaki MG, Stratigos AJ, et al. Sunscreens-what is important to know. J Eur Acad Dermatol Venereol. 2008;22:1110-8.
55. Green AC, Williams G, Neale R, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal cell and squamous cell carcinomas of the skin. A randomised controlled trial. Lancet. 1999;35:723-9.
56. Van der Pols JC, Russel A, Bauer U, et al. Vitamin D status and skin cancer risk independent of time outdoors: 11 year prospective study in an Australian community. J Invest Dermatol. 2013;133:637-41.
57. Green AC, Wiliams GM, Logan V, et al. Reduced melanoma incidence after regular sunscreen use. Randomized trial follow up. J Clin Oncol. 2011;29:257-63.
58. Huncharek M, Kupelnick P. Use of topical sunscreens and risk of malignant melanoma: a meta-analysis of 9067 patients from 11 case-control studies. Am J Public Health. 2002;92:1173-7.
59. Dennis LK, Beane Freeman LE, VanBeek MJ. Sunscreen use and the risk of melanoma. A quantitative review. Ann Intern Med. 2003;139:966-78.
60. Lazovich D, Vogel RI, Berwick M, et al. Melanoma risk in relation to use of sunscreen or other protection methods. Cancer Epidemiol Biomarkers Prev. 2011;20:2582-93.
61. Autier P, Dore JF, Schiffers E, et al. Melanoma and use of sunscreens. An EORTC case-control study in Germany, Belgium and France. The EORTC Melanoma Cooperative Group. 1995;61:749-55.
62. Nicol I, Gaudy C, Gouvernet J, et al. Skin protection by sunscreens is improved by explicit labeling and providing free sunscreen. J Invest Dermatol. 2007;127:41-8.
63. Loden M, Beitner H, Gonzalez H, et al. Sunscreen use, controversies, challenges and regulatory aspects. Br J Dermatol. 2011;165:255-62.
64. Krause M, Klit A, Blomberg Jensen M, et al. Sunscreens. Are they beneficial or health? An overview of endocrine disrupting properties of UV filters. Int J Androl. 2012;35:424-36.
65. Glass D, Lens M, Swaminathan R, Spector TD, Bataille V. Pigmentation and vitamin D metabolism in Caucasians: low vitamin D serum levels in fair skin types. PLoS One. 2009;4:e6477.
66. Field S, Newton Bishop JA. Melanoma and vitamin D. Mol Oncol. 2011;5:197-214.
67. 3 levels are associated with Breslow thickness at presentation and survival from melanoma. J Clin Oncol. 2009;27:5439-44.
68. Nam S, Kweon SS, Choi JJ, et al. Racial ethnic differences in bone mineral density among older women. J Bone Miner Metab. 2013;31:190-8.
69. Pilz S, Kienrich K, Tomaschitz A, et al. Vitamin D and cancer mortality: systematic review of prospective epidemiological studies. Anticancer Agents Med Chem. 2013;13:107-7.
70. Penat Chilet M, Ibarrola- Villava M, Martin Gonzalez M, et al. Rs12512631 on the group specific complement (vitamin D-binding protein GC) implicated in melanoma susceptibility. PLoS One. 2012;8(3):e59607.
71. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome wide association study. Lancet. 2010;376:180-8.
72. Beleza S, Santos AM, McEvoy B, et al. The timing of pigmentation in Europeans. Mol Biol Evol. 2013;30:24-35.